title: Poststroke fatigue following minor infarcts: a prospective study.
abstract: OBJECTIVE
  To explore the potential relationship between fatigue following strokes and poststroke mood, cognitive dysfunction, disability, and infarct site and to determine the predictive factors in the development of poststroke fatigue (PSF) following minor infarcts.
  
  
  METHODS
  Ninety-nine functionally active patients aged less than 70 years with a first, nondisabling stroke (NIH Stroke Scale score ≤6 in acute phase and ≤3 after 6 months, modified Rankin Scale score ≤1 at 6 months) were assessed during the acute phase and then at 6 (T1) and 12 months (T2) after their stroke. Scores in the Fatigue Assessment Inventory were described and correlated to age, gender, neurologic and functional impairment, lesion site, mood scores, neuropsychological data, laboratory data, and quality of life at T1 and T2 using a multivariate logistic regression analysis in order to determine which variables recorded at T1 best predicted fatigue at T2.
  
  
  RESULTS
  As many as 30.5% of the patients at T1 and 34.7% at T2 (11.6% new cases between T1 and T2) reported fatigue. At both 6 and 12 months, there was a significant association between fatigue and a reduction in professional activity. Attentional-executive impairment, depression, and anxiety levels remained associated with PSF throughout this time period, underlining the critical role of these variables in the genesis of PSF. There was no significant association between the lesion site and PSF.
  
  
  CONCLUSIONS
  This study suggests that attentional and executive impairment, as well as depression and anxiety, may play a critical role in the development of PSF.
authors.affiliation: Department of Neurology, University of Fribourg, Fribourg, Switzerland.
authors.forename: Narges
authors.initials: N
authors.lastname: Radman
authors.forename: Fabienne
authors.initials: F
authors.lastname: Staub
authors.forename: Tatiana
authors.initials: T
authors.lastname: Aboulafia-Brakha
authors.forename: Alexandre
authors.initials: A
authors.lastname: Berney
authors.forename: Julien
authors.initials: J
authors.lastname: Bogousslavsky
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Annoni
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D000368:Aged; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000209:etiology; D001921:Brain / Q000000981:diagnostic imaging / Q000473:pathology*; D020520:Brain Infarction / Q000209:etiology*; D003072:Cognition Disorders / Q000175:diagnosis / Q000209:etiology; D004185:Disability Evaluation; D005221:Fatigue / Q000209:etiology* / Q000378:metabolism; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008137:Longitudinal Studies; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D011569:Psychiatric Status Rating Scales; D011788:Quality of Life; D012044:Regression Analysis; D020521:Stroke / Q000150:complications / Q000378:metabolism / Q000523:psychology; D013972:Thyrotropin / Q000097:blood; D013997:Time Factors; D014057:Tomography, X-Ray Computed
chemical_list: D000324:Adrenocorticotropic Hormone; D013972:Thyrotropin; D006854:Hydrocortisone